Dec 19 (Reuters) - BioMarin Pharmaceutical (BMRN) said on Friday it would acquire Amicus Therapeutics (FOLD) for about $4.8 billion, expanding its presence in rare metabolic diseases.
The drugmaker will pay $14.50 per share for Amicus, a premium of 33.1% to the stock's last close. Shares of Amicus surged 30%, while BioMarin rose nearly 5% in premarket trading.
The deal strengthens BioMarin's portfolio with Amicus' approved genetic disorder treatments including Galafold, an oral drug for Fabry disease, which is caused by a faulty gene that leads to a buildup of fatty substances in cells.
Amicus also markets a combination therapy Pombiliti and Opfolda for Pompe disease, a genetic condition in which a complex sugar called glycogen builds up in the body's cells.
Amicus also has U.S. rights to DMX-200, a potential treatment of a type of kidney disease known as focal segmental glomerulosclerosis.
BioMarin intends to finance the deal through a combination of cash on hand and about $3.7 billion of non-convertible debt financing.
The company's total cash and investments at the end of September 30 were about $2 billion.
The acquisition, which is expected to close in the second quarter of 2026, will add revenue immediately after the transaction closes, BioMarin said.
The deal is also expected to add to adjusted profit in the first 12 months after close and be substantially accretive beginning in 2027, the company said.
(Reporting by Christy Santhosh and Sriparna Roy in Bengaluru; Editing by Leroy Leo and Maju Samuel)
LATEST POSTS
- 1
Audits of 6 European Busssiness Class Flights - 2Significant Elements to Consider Prior to Applying for a Mastercard: 6 Vital Contemplations
- 3NASA Artemis II tracker: Crew less than 60,000 miles from moon ahead of Monday flyby
- 4Jury says Johnson & Johnson owes $40 million to 2 cancer patients who used talcum powders
- 5Dave Coulier reveals he has tongue cancer, his 2nd diagnosis in a year, after beating non-Hodgkin lymphoma
- 5 Home EV Chargers for Proficient and Solid Charging
- KJ Apa stars as Jimmy Stewart in new biopic: See his transformation
- The most effective method to Amplify Profits from Gold Speculation: Systems and Tips
- Peloton recalls more than 800,000 bikes after broken seat posts injure users
- Vote In favor of Your Favored Sort Of Bevarage
- Dominating the Remote Work Way of life: Individual Systems
- Instructions to Perform Fundamental Upkeep on Your Slam 1500.
- Top notch Feasting: A Manual for Worldwide Acclaimed Eateries
- Instructions to Upgrade the Security Elements of Your Kona SUV
